The opportunity always arrives the same way. A partner has been talking to a landlord, or a behavioral health clinician, or a management company, and the conversation has gotten specific enough that there is now a number, a timeline, and a degree of enthusiasm that makes questions feel like obstruction. Everyone in the room supports growth in the abstract. What nobody has established is who decides, who pays, and who keeps the profit if it works.
Growth is where partnerships discover the gaps in their agreements, because expansion touches every provision at once: capital, governance, compensation, and exit value. A second location, a new service line, a telehealth platform, and an affiliation with a management services organization are different decisions with one thing in common. Each one is hard to reverse, and reversibility is what sets the threshold.
So put them on the reserved-matters catalog. Opening or closing a location, adding a service line, entering an ancillary venture, and entering or materially amending an affiliation each take a supermajority of two-thirds to 75 percent at a noticed meeting. Unanimity is the wrong setting—a universal veto eventually gets used as one, and a single partner should not be able to freeze a practice indefinitely. Simple majority is the wrong setting too, because a bare majority can commit the minority’s capital to a project they voted against and will still be funding in year four.
Require a written business plan before the vote, and require it far enough in advance to be read. The plan states the capital required and its sources, the ramp assumptions with the months they are drawn from, the break-even point, who staffs it and who covers the clinical schedule they leave behind, the effect on every partner’s compensation during the ramp, and what the practice does if the project misses its numbers by a stated margin. That last element is the one enthusiasm skips. A decision rule written before the launch—the trigger at which the partners revisit, restructure, or close—converts a future argument into a scheduled agenda item.
Then answer the funding question explicitly, per venture, because this is where growth disputes actually originate. Two designs are defensible and they are not interchangeable. In the practice-funded design, all partners contribute pro rata by ownership, and the venture’s profits and losses flow through ordinary distributions like any other practice activity. In the venture-funded design, a subset of partners funds the project and a separate, stated split applies to its returns, with the non-participating partners neither contributing nor sharing. What is never defensible is the accidental hybrid: two partners fund the buildout and five share the profit. That arrangement stalls the next expansion permanently, because nobody funds the second one.
Where the practice funds it, the capital-call mechanics belong in the agreement before any call is contemplated. Calls are authorized only by supermajority, for stated purposes. Written notice runs 30 to 60 days with the purpose, the total, and each partner’s share stated. Shares are pro rata by ownership, because capital defends the asset that equity owns. A stated annual cap keeps the obligation bounded and plannable. And the agreement names the consequence for the partner who cannot pay, with the partner-loan mechanism fitting physician groups best: contributing partners fund the shortfall as a loan at a stated rate, repaid by withholding from the borrower’s future distributions over a bounded term, with the ownership table untouched.
One practice’s second location shows the machinery working. Acme Pediatrics—four physicians, roughly $2.6 million in annual collections, a panel 44 percent Medicaid—voted to build out a second site at the supermajority its agreement required. The project ran $1.9 million: $700,000 on a term loan and $1.2 million by capital call, or $300,000 per partner, staged across three tranches over 18 months. The annual cap forced the staging. No partner could be called for more than $120,000 in a calendar year, a ceiling the partners had set years earlier with a second location already in mind, so the schedule dropped one $100,000 tranche into each of three calendar years and a terrifying number became three plannable ones. Then the edge cases arrived on cue. One partner, at 0.7 clinical full-time equivalent, contributed a full pro rata share, because capital obligations follow ownership rather than schedule—a distinction the agreement had made explicitly. Another, mid-divorce with frozen liquidity, could not fund the second tranche, and the partner-loan mechanism executed as designed: the three contributing partners funded her $100,000 at prime plus two, repaid by distribution withholding over 30 months, ownership percentages unchanged. What the partners cite when they tell the story is what never happened. No meeting was required, because the consequence was already law.
Three growth categories carry their own drafting notes. Telehealth expansion needs the platform decision, the state-licensure question for any patient who crosses a border, the liability allocation when clinical software errs, and the revenue attribution rule for asynchronous work—all decided at partnership level rather than accumulated as individual habits. Ancillary ventures in behavioral health, laboratory, imaging, and developmental testing need the profit split per venture and a compliance review, because designated health services change the analysis under the Stark law and the Anti-Kickback Statute, and whether a given arrangement fits an exception or a safe harbor is counsel’s determination made before the venture opens. Integrated behavioral health also frequently runs at a loss for its first stretch, which is a reason to define the loss-sharing rule, not a reason to skip the service.
Affiliation with a management services organization is the decision most likely to change governance permanently, and the one most often presented as an operational upgrade. Entering, materially amending, renewing, or terminating such an arrangement belongs at the fundamental tier with full written disclosure to every partner in advance—the fee schedule, the term, the termination rights, the services promised, and the ownership of the counterparty. Article 47 works that structure in detail.
Red flags. Growth decisions made by the managing partner or the most entrepreneurial partner without a vote. A new location funded by willing partners with profits shared practice-wide. An ancillary venture that creates a conflict of interest nobody disclosed. An affiliation that alters the governance structure permanently without an explicit partner vote. Telehealth liability and licensure left unallocated. And a business plan produced after the decision, to justify it.
Growth is the best thing that happens to a healthy practice and the fastest way to break an unhealthy one. The difference is not the opportunity. It is whether the partners decided how to decide before the opportunity showed up. Growth that is not governed is not strategy. It is just spending.
A supermajority of two-thirds to 75 percent at a noticed meeting. Unanimity is the wrong setting, because a universal veto eventually gets used as one and a single partner should not be able to freeze a practice indefinitely. Simple majority is wrong too, since a bare majority can commit the minority's capital to a project they voted against.
Two designs are defensible and they are not interchangeable. Practice-funded: all partners contribute pro rata by ownership, and profits and losses flow through ordinary distributions. Venture-funded: a subset of partners funds the project under a separate stated split, with non-participants neither contributing nor sharing. The accidental hybrid stalls the next expansion permanently.
The partner-loan mechanism fits physician groups best. Contributing partners fund the shortfall as a loan at a stated rate, repaid by withholding from the borrower's future distributions over a bounded term, with the ownership table untouched. In one practice, three partners funded a colleague's $100,000 tranche at prime plus two, repaid over 30 months.
The Partnership Agreement Analyzer scores an existing agreement against the framework this series is built on — or schedule a discovery call to work through it with PMI. The full framework, with the arithmetic, lives in the textbook Pediatric Practice Management: The Fundamentals.